ERBB2 and breast cancer: The major achievement of this study is to prepare a new nanobubble that can be served as a bimodal imaging agent in both contrast-enhanced ultrasound (CEUS) and optical imaging for patients with breast cancer to identify both primary tumor and small metastasis and also determine the expression status of HER2 within tumor.